Related Experiment Video
Updated: May 8, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
Advances in the understanding of the Fanconi anemia tumor suppressor pathway
Anna Pickering1, Jun Zhang2, Jayabal Panneerselvam1
1University of Hawaii Cancer Center; University of Hawaii; Honolulu, HI USA.
Abstract:
Extremely high cancer incidence in Fanconi anemia (FA) patients has long suggested that the FA signaling pathway is a tumor suppressor pathway. Indeed, our recent findings, for the first time, indicate that the FA pathway plays a significant role in suppressing the development of non-FA human cancer. Also our studies on FA group D2 protein (FANCD2) have, among the first, documented the crosstalks between the FA and Rad6/Rad18 (HHR6) pathways upon DNA damage. In this review, we will discuss how our studies enhance the understanding of the FA tumor suppressor pathway.
Insights
Fanconi anemia (FA) pathway is a tumor suppressor, crucial for preventing non-FA cancers. Our research clarifies its role and interaction with DNA repair pathways like Rad6/Rad18 (HHR6).
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Fanconi anemia (FA) is linked to exceptionally high cancer rates, suggesting the FA pathway's tumor suppressor function.
- Previous research has not fully elucidated the FA pathway's role in non-hereditary cancers.
Purpose of the Study:
- To investigate the role of the Fanconi anemia (FA) pathway in suppressing the development of non-FA human cancers.
- To explore the interplay between the FA pathway and the Rad6/Rad18 (HHR6) pathway in DNA damage response.
Main Methods:
- Review of existing studies on Fanconi anemia (FA) pathway and its components, including FANCD2.
- Analysis of DNA damage response mechanisms and pathway crosstalk.
Main Results:
- The Fanconi anemia (FA) pathway demonstrates a significant tumor-suppressive role in non-FA human cancers.
- The Fanconi anemia group D2 protein (FANCD2) is involved in the crosstalk between FA and Rad6/Rad18 (HHR6) pathways following DNA damage.
Conclusions:
- Our findings provide novel insights into the Fanconi anemia (FA) pathway's function as a tumor suppressor in a broader context beyond FA.
- Understanding the FA pathway's interactions with other DNA repair mechanisms enhances our knowledge of cancer development and prevention.
More Related Videos
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

